Andrea S. Bonzini
Many people have been affected by neurological illnesses, which range from epilepsy to Alzheimer's disease, stroke, and headache. According to the World Health Organization, around 6.8 million people die each year as a result of neurological illnesses. In 2004, the economic cost of neurological illnesses in Europe was estimated to be over 139 billion euros.
The massive growth in the global market for neurological devices demonstrates the increasing prevalence of cerebral stroke, acute and chronic disorders such as epilepsy, Alzheimer's, Parkinson's, Huntington's, Movement Disorders, Ataxia, Cerebrovascular disease, Multiple Sclerosis, and other neurological disorders.
It is estimated that 50 million people in the United States are impacted by neurological illnesses, which result in high-cost treatment options. According to Transparency Market Research, the inspiring step, which was provided in a recent report for neuroscience marketing devices, will reach a value of USD 13.6 billion in 2021.
According to the World Health Organization, over 14% of people would suffer from neurological illnesses by 2021.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi